{"slideshow_credits": null, "snippet": "An insurance executive criticizes the high cost that drug manufacturers charge for new drugs as \u201cexploitation.\u201d", "abstract": null, "section_name": "Opinion", "print_page": "22", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2015/09/14/opinion/inflated-drug-prices.html", "lead_paragraph": "An insurance executive criticizes the high cost that drug manufacturers charge for new drugs as \u201cexploitation.\u201d", "headline": {"print_headline": "Inflated Drug Prices", "main": "Inflated Drug Prices", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "55f6752938f0d85cacd390d0", "word_count": "221", "multimedia": [], "pub_date": "2015-09-14T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Health Insurance and Managed Care", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}